2018
DOI: 10.1186/s12882-018-1166-0
|View full text |Cite
|
Sign up to set email alerts
|

Comparing the vascular thromboembolic events following arteriovenous fistula in Chinese population with end-stage renal diseases receiving Clopidogrel versus Beraprost sodium therapy: a retrospective cohort study

Abstract: BackgroundTo assess the time to first on-study vascular thromboembolic events (VTEs) of clopidogrel (CL) or beraprost sodium (BPS) in Chinese population with end-stage renal disease (ESRD) treated with arteriovenous fistula (AVF) surgery.MethodsFrom Jan 2009 to May 2015, 346 ESRD cases suffering an AVF surgery and undergoing oral administration of 75 mg CL (initial dose of 300 mg), 1 time/day, for 4 weeks or 40 μg BPS, 3 times/day, for 4 weeks were retrospectively assessed. The primary outcome was time to firs… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 33 publications
0
1
0
Order By: Relevance
“…[ 2 ] Some patients with chronic renal failure need long-term MHD to prolong their lives and wait for the opportunity of kidney transplantation, and establishing high patency vascular access is a prerequisite for dialysis. [ 3 ] Improving hemodialysis patency is still a significant clinical issue that must be addressed. The Renal Disease Dialysis Guidelines recommend autologous arteriovenous fistulas or human-made vascular fistulas as vascular access for hemodialysis expected to be performed for more than 1 year.…”
Section: Introductionmentioning
confidence: 99%
“…[ 2 ] Some patients with chronic renal failure need long-term MHD to prolong their lives and wait for the opportunity of kidney transplantation, and establishing high patency vascular access is a prerequisite for dialysis. [ 3 ] Improving hemodialysis patency is still a significant clinical issue that must be addressed. The Renal Disease Dialysis Guidelines recommend autologous arteriovenous fistulas or human-made vascular fistulas as vascular access for hemodialysis expected to be performed for more than 1 year.…”
Section: Introductionmentioning
confidence: 99%